Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yokukansan for prevention of postoperative delirium after gastrointestinal cancer surgery
jRCTs061180007Completed
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of yokukansan in postoperative delirium (POD) (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Jul 2017; status: completed.
02
Drugs
yokukansan
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on jRCTs061180007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180007.